HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kim, S. P. Articles by Bergman, R. N. Search for Related Content PubMed PubMed Citation Articles by Kim, S. P. Articles by Bergman, R. N. Social Bookmarking                What's this?

Primacy of Hepatic Insulin Resistance in the Development of the Metabolic Syndrome Induced by an Isocaloric Moderate-Fat Diet in the Dog

From the Department of Physiology and Biophysics, University of Southern California Keck School of Medicine, Los Angeles, California

Obesity is highly correlated with insulin resistance and the development of type 2 diabetes. Insulin resistance will result in a decrease in insulin’s ability to stimulate glucose uptake into peripheral tissue and will suppress glucose production by the liver. However, the development of peripheral and hepatic insulin resistance relative to one another in the context of obesity-associated insulin resistance is not well understood. To examine this phenomena, we used the moderate fat-fed dog model, which has been shown to develop both subcutaneous and visceral adiposity and severe insulin resistance. Six normal dogs were fed an isocaloric diet with a modest increase in fat content for 12 weeks, and they were assessed at weeks 0, 6, and 12 for changes in insulin sensitivity and glucose turnover. By week 12 of the diet, there was a more than twofold increase in trunk adiposity as assessed by magnetic resonance imaging because of an accumulation in both subcutaneous and visceral fat depots with very little change in body weight. Fasting plasma insulin had increased by week 6 (150% of week 0) and remained increased up to week 12 of the study (170% of week 0). Surprisingly, there appeared to be no change in the rates of insulin-stimulated glucose uptake as measured by euglycemic-hyperinsulinemic clamps throughout the course of fat feeding. However, there was an increase in steady-state plasma insulin levels at weeks 6 and 12, indicating a moderate degree of peripheral insulin resistance. In contrast to the moderate defect seen in the periphery, there was a marked impairment in insulin’s ability to suppress endogenous glucose production during the clamp such that by week 12 of the study, there was a complete inability of insulin to suppress glucose production. Our results indicate that a diet enriched with a moderate amount of fat results in the development of both subcutaneous and visceral adiposity, hyperinsulinemia, and a modest degree of peripheral insulin resistance. However, there is a complete inability of insulin to suppress hepatic glucose production during the clamp, suggesting that insulin resistance of the liver may be the primary defect in the development of insulin resistance associated with obesity.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. R Hsu, S. P Kim, M. Kabir, and R. N Bergman Metabolic syndrome, hyperinsulinemia, and cancer Am. J. Clinical Nutrition, September 1, 2007; 86(3): 867S - 871S. [Abstract] [Full Text] [PDF]

				R. N. Bergman Orchestration of Glucose Homeostasis: From a Small Acorn to the California Oak Diabetes, June 1, 2007; 56(6): 1489 - 1501. [Full Text] [PDF]

				S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598. [Abstract] [Full Text] [PDF]

				S. P. Kim, M. Ellmerer, E. L. Kirkman, and R. N. Bergman beta-Cell "rest" accompanies reduced first-pass hepatic insulin extraction in the insulin-resistant, fat-fed canine model Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1581 - E1589. [Abstract] [Full Text] [PDF]

				N. Sattar, A. McConnachie, I. Ford, A. Gaw, S. J. Cleland, N. G. Forouhi, P. McFarlane, J. Shepherd, S. Cobbe, and C. Packard Serial Metabolic Measurements and Conversion to Type 2 Diabetes in the West of Scotland Coronary Prevention Study: Specific Elevations in Alanine Aminotransferase and Triglycerides Suggest Hepatic Fat Accumulation as a Potential Contributing Factor Diabetes, April 1, 2007; 56(4): 984 - 991. [Abstract] [Full Text] [PDF]

				M. Hoenig, K. Thomaseth, M. Waldron, and D. C. Ferguson Insulin sensitivity, fat distribution, and adipocytokine response to different diets in lean and obese cats before and after weight loss Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R227 - R234. [Abstract] [Full Text] [PDF]

				K. M. Utzschneider and S. E. Kahn The Role of Insulin Resistance in Nonalcoholic Fatty Liver Disease J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4753 - 4761. [Abstract] [Full Text] [PDF]

				P. J. Raubenheimer, M. J. Nyirenda, and B. R. Walker A Choline-Deficient Diet Exacerbates Fatty Liver but Attenuates Insulin Resistance and Glucose Intolerance in Mice Fed a High-Fat Diet. Diabetes, July 1, 2006; 55(7): 2015 - 2020. [Abstract] [Full Text] [PDF]

				A. J. German The Growing Problem of Obesity in Dogs and Cats J. Nutr., July 1, 2006; 136(7): 1940S - 1946S. [Abstract] [Full Text] [PDF]

				M. Ellmerer, M. Hamilton-Wessler, S. P. Kim, K. Huecking, E. Kirkman, J. Chiu, J. Richey, and R. N. Bergman Reduced Access to Insulin-Sensitive Tissues in Dogs With Obesity Secondary to Increased Fat Intake Diabetes, June 1, 2006; 55(6): 1769 - 1775. [Abstract] [Full Text] [PDF]

				M D. Robertson, A. S Bickerton, A L. Dennis, H. Vidal, and K. N Frayn Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism Am. J. Clinical Nutrition, September 1, 2005; 82(3): 559 - 567. [Abstract] [Full Text] [PDF]

				J. M. Miles and M. D. Jensen Counterpoint: Visceral Adiposity Is Not Causally Related to Insulin Resistance Diabetes Care, September 1, 2005; 28(9): 2326 - 2328. [Full Text] [PDF]

				D. S. Kronfeld, K. H. Treiber, T. M. Hess, and R. C. Boston Insulin resistance in the horse: Definition, detection, and dietetics J Anim Sci, June 1, 2005; 83(13_suppl): E22 - 31. [Abstract] [Full Text] [PDF]

				J. Westerbacka, K. Lammi, A.-M. Hakkinen, A. Rissanen, I. Salminen, A. Aro, and H. Yki-Jarvinen Dietary Fat Content Modifies Liver Fat in Overweight Nondiabetic Subjects J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2804 - 2809. [Abstract] [Full Text] [PDF]

				K. H. Pietilainen, A. Rissanen, J. Kaprio, S. Makimattila, A.-M. Hakkinen, J. Westerbacka, J. Sutinen, S. Vehkavaara, and H. Yki-Jarvinen Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E768 - E774. [Abstract] [Full Text] [PDF]

				M. Ader, S. P. Kim, K. J. Catalano, V. Ionut, K. Hucking, J. M. Richey, M. Kabir, and R. N. Bergman Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs Diabetes, March 1, 2005; 54(3): 862 - 871. [Abstract] [Full Text] [PDF]

				M. Kabir, K. J. Catalano, S. Ananthnarayan, S. P. Kim, G. W. Van Citters, M. K. Dea, and R. N. Bergman Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance Am J Physiol Endocrinol Metab, February 1, 2005; 288(2): E454 - E461. [Abstract] [Full Text] [PDF]

				M. Recasens, A. Lopez-Bermejo, W. Ricart, J. Vendrell, R. Casamitjana, and J. M. Fernandez-Real An Inflammation Score Is Better Associated with Basal than Stimulated Surrogate Indexes of Insulin Resistance J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 112 - 116. [Abstract] [Full Text] [PDF]

				M. E. Cleasby, N. Dzamko, B. D. Hegarty, G. J. Cooney, E. W. Kraegen, and J.-M. Ye Metformin Prevents the Development of Acute Lipid-Induced Insulin Resistance in the Rat Through Altered Hepatic Signaling Mechanisms Diabetes, December 1, 2004; 53(12): 3258 - 3266. [Abstract] [Full Text] [PDF]

				S. P. Bagby Obesity-Initiated Metabolic Syndrome and the Kidney: A Recipe for Chronic Kidney Disease? J. Am. Soc. Nephrol., November 1, 2004; 15(11): 2775 - 2791. [Full Text] [PDF]

				A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R. A. DeFronzo Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3914 - 3921. [Abstract] [Full Text] [PDF]

				M. F. Dallman, S. E. la Fleur, N. C. Pecoraro, F. Gomez, H. Houshyar, and S. F. Akana Minireview: Glucocorticoids--Food Intake, Abdominal Obesity, and Wealthy Nations in 2004 Endocrinology, June 1, 2004; 145(6): 2633 - 2638. [Abstract] [Full Text] [PDF]